Association Between SGLT2 Inhibitor Treatment and DKA and Mortality in People With Type 2 Diabetes Hospitalised for COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes Care
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Association Between SGLT2 Inhibitor Treatment and Diabetic Ketoacidosis and Mortality in People With Type 2 Diabetes Admitted to Hospital With COVID-19
Diabetes Care 2022 Sep 08;[EPub Ahead of Print], K Khunti, Y Ruan, J Davies, BCT Field, S Harris, M Kosiborod, D Nagi, P Narendran, D Patel, REJ Ryder, KA Várnai, SH Wild, EG Wilmot, R ReaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.